Patent · US Active

Norepinephrine compositions and methods therefor

US11602508B2 · kind B2 · utility

1Cited by
22References
10Claims
0Family size

Assignee

Inventors

Key dates

Filing dateJul 25, 2022
Grant dateMar 14, 2023
Priority date
Expiry dateJul 25, 2042

Classification

  • Technology area (CPC Y)Emerging Cross-Sectional Technologies
  • CPC primaryY02A50/30
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

The inventive subject matter is directed to compositions and methods for ready-to-inject norepinephrine compositions with improved stability. Most preferably, compositions presented herein are substantially antioxidant free and exhibit less than 10% isomerization of R-norepinephrine and exhibit less than 5% degradation of total norepinephrine.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.